Company Profile

JIANGSU XINRUI PHARMACEUTICAL CO., LTD.
Year Established : 2012
Total Assets(USD) : 10,000,000 To 14,999,999
Total Number of Staff : 80 to 89
Main Competitive Advantages : International Approvals/Standards,Production capacity,Large Product Line

As a high-tech enterprise,Jiangsu Xinrui Pharmaceutical Co., Ltd devotes to manufacturing advanced Pharmaceutical Intermidates and APIs. The plant is strictly in accordance with FDA and COS standard. It owns one GMP workshop for Valsartan API and production lines for Olmesartan, Rosuvatatin, Sitagliptin, 4-Fluoro-3-Phenoxybenzaldehyde and 3,3-Dimethylbutyryl Chloride. Kaiyuan has years experience in the reactions  such as Grignard, Coupling, Chiral synthesis, Halogenation, Oxidation, Etherification, Cyclic, Condersation and etc.

PharmaSources Customer Service